However, in multivariate analyses, only tumor stage, nodal stage, hormone-receptor status, and HER2 status significantly predicted OS, while the final model for breast-cancer-specific survival additionally included tumor grade (Table 2). This evidence concerns the gene ERBB2 and breast cancer.